SE8902235D0 - NOVEL CYCLODEXTRIN INCLUSION COMPLEXES - Google Patents

NOVEL CYCLODEXTRIN INCLUSION COMPLEXES

Info

Publication number
SE8902235D0
SE8902235D0 SE8902235A SE8902235A SE8902235D0 SE 8902235 D0 SE8902235 D0 SE 8902235D0 SE 8902235 A SE8902235 A SE 8902235A SE 8902235 A SE8902235 A SE 8902235A SE 8902235 D0 SE8902235 D0 SE 8902235D0
Authority
SE
Sweden
Prior art keywords
cyclodextrin inclusion
inclusion complexes
novel cyclodextrin
complex
preparation
Prior art date
Application number
SE8902235A
Other languages
Swedish (sv)
Inventor
B M Lindstedt
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8902235A priority Critical patent/SE8902235D0/en
Publication of SE8902235D0 publication Critical patent/SE8902235D0/en
Priority to IE216290A priority patent/IE902162A1/en
Priority to DD90341729A priority patent/DD297404A5/en
Priority to GR900100458A priority patent/GR1000747B/en
Priority to JP2509477A priority patent/JPH04506212A/en
Priority to PT94415A priority patent/PT94415A/en
Priority to PCT/SE1990/000436 priority patent/WO1990015792A1/en
Priority to CA002058996A priority patent/CA2058996A1/en
Priority to EP90910159A priority patent/EP0478677A1/en
Priority to KR1019910701912A priority patent/KR920702674A/en
Priority to AU59374/90A priority patent/AU641670B2/en
Priority to HU905542A priority patent/HUT59085A/en
Priority to NO91914927A priority patent/NO914927L/en
Priority to FI915935A priority patent/FI915935A0/en
Priority to LV930886A priority patent/LV10249A/en
Priority to LTIP1725A priority patent/LTIP1725A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

An inclusion complex of 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]amino]-2-hydroxypropoxy]-benzon itrile having formula (I) with one or more cyclodextrins, which is useful for the treatment of cardiac arrhythmias, process for the preparation of said complex as well as the use of said complex for the preparation of medicaments with action against cardiac arrhythmias.
SE8902235A 1989-06-20 1989-06-20 NOVEL CYCLODEXTRIN INCLUSION COMPLEXES SE8902235D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE8902235A SE8902235D0 (en) 1989-06-20 1989-06-20 NOVEL CYCLODEXTRIN INCLUSION COMPLEXES
IE216290A IE902162A1 (en) 1989-06-20 1990-06-15 Novel cyclodextrin inclusion complexes
DD90341729A DD297404A5 (en) 1989-06-20 1990-06-16 PROCESS FOR PREPARING A SALT OF THE COMPOUND 4- [3- [ETHYL- (3- (PROPYLSULFINYL) -PROPYL] -AMINO) -2-HYDROXY-PROPOXY] -BENZONITRILE
GR900100458A GR1000747B (en) 1989-06-20 1990-06-18 Novel cyclodextrin inclusion complexes
HU905542A HUT59085A (en) 1989-06-20 1990-06-19 Process for producing new cyclodextrine inclusion-complexes and pharmaceutical compositions containing them
PCT/SE1990/000436 WO1990015792A1 (en) 1989-06-20 1990-06-19 Novel cyclodextrin inclusion complexes
PT94415A PT94415A (en) 1989-06-20 1990-06-19 METHOD FOR THE PREPARATION OF NEW INCLUSIVE COMPLEXES DERIVED FROM THE COMPOUND 4- 3-ETHYL-3- (PROPYLSULFINYL) -OPOPYLAMINO-2-HYDROXYPROPOXYBENZONITRYL AND OF CYCLLODEXTRINS AND OF THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2509477A JPH04506212A (en) 1989-06-20 1990-06-19 Novel cyclodextrin inclusion complex
CA002058996A CA2058996A1 (en) 1989-06-20 1990-06-19 Cyclodextrin inclusion complexes
EP90910159A EP0478677A1 (en) 1989-06-20 1990-06-19 Novel cyclodextrin inclusion complexes
KR1019910701912A KR920702674A (en) 1989-06-20 1990-06-19 New Cyclodextrin Inclusion Complexes
AU59374/90A AU641670B2 (en) 1989-06-20 1990-06-19 Novel cyclodextrin inclusion complexes
NO91914927A NO914927L (en) 1989-06-20 1991-12-13 NEW CYCLODE EXTRA INCLUSION COMPLEXS
FI915935A FI915935A0 (en) 1989-06-20 1991-12-17 NYA CYKLODEXTRININKLUSIONSKOMPLEXER.
LV930886A LV10249A (en) 1989-06-20 1993-06-30 New cyclodextrin inclusions complexity and application
LTIP1725A LTIP1725A (en) 1989-06-20 1993-12-30 Novel cyclodextrin inclusion complexes and process for preparing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902235A SE8902235D0 (en) 1989-06-20 1989-06-20 NOVEL CYCLODEXTRIN INCLUSION COMPLEXES

Publications (1)

Publication Number Publication Date
SE8902235D0 true SE8902235D0 (en) 1989-06-20

Family

ID=20376340

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902235A SE8902235D0 (en) 1989-06-20 1989-06-20 NOVEL CYCLODEXTRIN INCLUSION COMPLEXES

Country Status (15)

Country Link
EP (1) EP0478677A1 (en)
JP (1) JPH04506212A (en)
KR (1) KR920702674A (en)
AU (1) AU641670B2 (en)
CA (1) CA2058996A1 (en)
DD (1) DD297404A5 (en)
FI (1) FI915935A0 (en)
GR (1) GR1000747B (en)
HU (1) HUT59085A (en)
IE (1) IE902162A1 (en)
LT (1) LTIP1725A (en)
LV (1) LV10249A (en)
PT (1) PT94415A (en)
SE (1) SE8902235D0 (en)
WO (1) WO1990015792A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
DE4227569C1 (en) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Enzymatic determn. of inorganic phosphate - using combination of di:saccharide phosphorylase, phosphatase or maltose synthase, and glucose oxido-reductase
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
TWI373473B (en) * 2005-09-02 2012-10-01 Otsuka Pharma Co Ltd Anticancer agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457876A (en) * 1972-12-15 1976-12-08 Ici Ltd Alkanolamine derivatives device for use in
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives
HU177081B (en) * 1978-12-12 1981-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing the occlusion complex of allicin with cyclodextrin
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS5718602A (en) * 1980-05-28 1982-01-30 Hokko Chem Ind Co Ltd Herbicide
EP0094157B1 (en) * 1982-04-30 1987-07-29 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its use
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
SE8902237D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL STEREOISOMERS
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
EP0478677A1 (en) 1992-04-08
IE902162A1 (en) 1991-01-02
LV10249A (en) 1994-10-20
KR920702674A (en) 1992-10-06
PT94415A (en) 1991-02-08
AU5937490A (en) 1991-01-08
LTIP1725A (en) 1995-07-25
AU641670B2 (en) 1993-09-30
DD297404A5 (en) 1992-01-09
IE902162L (en) 1990-12-20
WO1990015792A1 (en) 1990-12-27
JPH04506212A (en) 1992-10-29
CA2058996A1 (en) 1990-12-21
GR1000747B (en) 1992-12-30
HUT59085A (en) 1992-04-28
GR900100458A (en) 1991-11-15
FI915935A0 (en) 1991-12-17
HU905542D0 (en) 1992-03-30

Similar Documents

Publication Publication Date Title
KR890701107A (en) Compounds for the treatment of Alzheimer's disease
TR200201059T2 (en) Novel oxabispidine compounds useful in the treatment of cardiac arrhythmias
BR0016678A (en) Compound, pharmaceutical formulation, use of a compound, method for prophylaxis or treatment of an arrhythmia, and, process for preparing a compound
SE8902235D0 (en) NOVEL CYCLODEXTRIN INCLUSION COMPLEXES
SE0100326D0 (en) New compounds
ES549515A0 (en) PROCEDURE FOR THE FURTHER TREATMENT OF WASHED CLOTHING
SE8102337L (en) RADIORECEIVER
NO305655B1 (en) Antiarrhythmic and cardioprotective substituted indenoylguanidines, their use in the manufacture of drugs, and drugs containing these
FI793459A (en) ESTRAR AV 1,1,2-TRIPHENYL ALKENDERIVAT
KR910009270A (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compound
ATE167804T1 (en) USE OF NICKEL AND BROMIDE IONS FOR THE TREATMENT OF PSORIASIS
YU120590A (en) NEW POLYSTYRENESULPHONATE
SE0003795D0 (en) Pharmaceutically useful compounds
DE69018099D1 (en) Polyamine derivatives as antineoplastic agents.
DE3467161D1 (en) UNSATURATED ARYLALKYL AMMONIUM SALTS
BR0011667A (en) Compound, pharmaceutical formulation, use of a compound, prophylaxis method or treatment of an arrhythmia, and process of preparing a compound
SE9902268D0 (en) Pharmaceutically active compounds
TH24865B (en) Process for producing epoxides from olefins
SE0002603D0 (en) New compounds
NO903585L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-OCSAZINES.
IT1240036B (en) PROCESS FOR THE MANUFACTURE OF BRUSHES, AS WELL AS THE MACHINE FOR THE MANUFACTURE OF BRUSHES FOR THE EXECUTION OF THE PROCEDURE
DE3774715D1 (en) CARDIOTONIC IMIDAZOLYLPHENYLPYRROL-2-ONE.
TH24865A (en) Process for producing epoxides from olefins
TH4688EX (en) Tetrahydronaphthalene derivatives
JO1673B1 (en) Novel polystyrenesulfonate